|本期目录/Table of Contents|

[1]王 艳,郭 志,杨雪玲,等.CT引导下125I粒子植入对缓解胰腺癌疼痛的疗效观察[J].天津医科大学学报,2019,25(02):132-135.
 WANG Yan,GUO Zhi,YANG Xue-ling,et al.CT-guided iodine-125 seeds implantation therapy for pancreatic cancer patients with pain[J].Journal of Tianjin Medical University,2019,25(02):132-135.
点击复制

CT引导下125I粒子植入对缓解胰腺癌疼痛的疗效观察(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
25
期数:
2019年02期
页码:
132-135
栏目:
临床医学
出版日期:
2019-03-20

文章信息/Info

Title:
CT-guided iodine-125 seeds implantation therapy for pancreatic cancer patients with pain
文章编号:
1006-8147(2019)02-0132-04
作者:
王 艳郭 志杨雪玲于海鹏司同国张炜浩常 旭
(天津医科大学肿瘤医院介入科,国家肿瘤临床医学研究中心,天津市“肿瘤防治”重点实验室,天津市恶性肿瘤临床医学研究中心,天津300060)
Author(s):
WANG Yan GUO Zhi YANG Xue-ling YU Hai-peng SI Tong-guo ZHANG Wei-hao CHANG Xu
(Department of Interventional Therapy,Cancer Institute and Hospital,Tianjin Medical University, National Clinical Research Center of Cancer,Key Laboratory of Cancer Prevention and Therapy of Tianjin,Tianjin 300060,China)
关键词:
胰腺癌近距离放射疗法疼痛
Keywords:
pancreatic cancer brachytherapy pain
分类号:
R735.9
DOI:
-
文献标志码:
A
摘要:
目的:观察胰腺癌患者行125I粒子植入术后的癌痛缓解情况,评价粒子植入治疗的有效性及安全性。方法:28例晚期不可手术切除胰腺癌伴癌痛患者,术前应用治疗计划系统(TPS)计算布源,在CT引导下将125I粒子植入胰腺病灶。随访观察患者疼痛缓解率,术前与术后疼痛视觉模拟评分(VAS)变化情况,阿片类止痛药使用情况以及生活质量评分情况。结果: 125I粒子植入术后1周、1月及3月,患者疼痛缓解有效率分别为82.1%(23/28)、67.9%(19/28)、57.1%(16/28)。VAS疼痛评分分别为(2.3±1.2)、(2.9±1.5)、(4.1±1.4)分,明显低于术前基线水平[(7.2±1.1)分]。阿片类止痛药使用量明显降低(P<0.01),总体生活质量较前明显改善(P<0.01)。近期不良反应轻微,无严重并发症。结论:CT引导下125I粒子植入可以有效缓解胰腺癌患者疼痛状况,明显改善患者总体生活质量。
Abstract:
Objective: To evaluate the safety and efficacy of CT-guided radioactive seeds 125I implantation in relieving the pain of advanced pancreatic cancer patients. Methods: Twenty-eight unresectable pancreatic cancer patients with pain were studied. Treatment plan system(TPS) was used to determine the number and distribution of 125I seeds. 125Iseeds were implanted into the lesions under CT-guided. The assessment included the visual analogue scale(VAS), quality of life, and 24 h consumption of opioids. Results: The effective rates of pain reliefinpatients were 82.1%(23/28), 67.9%(19/28), 57.1%(16/28)at 1 week, 1 month and 3 months post-procedure. VAS scores decreased from 7.2±1.1 to 2.3±1.2, 2.9±1.5 and 4.1±1.4 at 1 week, 1 month and 3months post-procedure, respectively. With the quality of life significantly improved (P<0.01), 24h consumption of opioids were decreased significantly compared with pre-procedure(P<0.01). No severe complications caused by technique were detected. Conclusion:CT-guided radioactive 125I seeds implantation is safe and effective in relieving the pain and improving the quality of life of pancreatic cancer patients.

参考文献/References:


[1] Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5):E359
[2] Bosetti C, Bertuccio P, Negri E, et al. Pancreatic cancer:overview of descriptive epidemiology[J]. Mol Carcinog, 2012, 51(1):3
[3] Grahm A L, Andren-Sandberg A. Prospective evaluation of pain in exocrine pancreatic cancer[J]. Digestion,1997, 58(6):542
[4] Kiagia M, Syrigos K N, Saif M W. Quality of Life in patients with pancreatic cancer[J]. JOP, 2014, 15(4):317
[5] Velanovich V. The association of Quality-of-Life measures with malignancy and survival in patients with pancreatic pathology[J].Pancreas, 2011, 40(7):1063
[6] 杨尹默, 刘子文, 赵玉沛, 等. 胰腺癌诊治指南(2014) [J]. 临床肝胆病杂志, 2014, 12: 1240
[7] Dobosz L, Kaczor M, Stefaniak T J. Pain in pancreatic cancer: review of medical and surgical remedies[J]. ANZ J Surg, 2016, 86(10):756.
[8] Wolny-Rokicka E, Sutkowski K, Grzadziel A, et al. Tolerance and efficacy of palliative radiotherapy for advanced pancreatic cancer:A retrospective analysis of single-institutional experiences[J]. Mol Clin Oncol, 2016, 4(6):1088
[9] Nagels W, Pease N, Bekkering G, et al. Celiac plexus neurolysis for abdominal cancer pain: a systematic review[J]. Pain Med, 2013, 14(8):1140
[10] Ma Z H, Yang Y, Zou L, et al. 125I seed irradiation induces up-regulation of the genes associated with apoptosis and cell cycle arrest and inhibits growth of gastric cancer xenografts[J]. J Exp Clin Cancer Res, 2012, 31:61
[11] Ma J X, Jin Z D, Si P R, et al. Continuous and low-energy 125I seed irradiation changes DNA methyltransferases expression patterns and inhibits pancreatic cancer tumor growth[J]. J Exp Clin Cancer Res,2011, 30:35
[12] 张炜浩, 郭志, 李保国, 等. CT导向下125I粒子植入补救治疗盆腔恶性肿瘤近期疗效评价 [J]. 介入放射学杂志, 2013, 4: 308
[13] 王营,郭志,张炜浩,等.CT引导下125I粒子植入治疗复发性卵巢癌17例[J].介入放射学杂志,2015,24(1):55
[14] Wu H M, Lü J, Hu W L, et al. Combination of transrectal 125I seeds implantation brachytherapy and intermittent hormonal therapy for locally advanced prostate cancer[J]. Zhonghua Nan Ke Xue 2013, 19(7): 617
[15] Liu K, Ji B, Zhang W, et al. Comparison of iodine-125 seed implantation and pancreaticoduodenectomy in the treatment of pancreatic cancer[J].Int J Med Sci,2014,11(9):893
[16] Jin Z, Du Y, Li Z, et al. Endoscopic ultrasonography-guided interstitial implantation of Iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study[J]. Endoscopy, 2008,40(4):314
[17] Wang Z M, Liu Y, Liu F J, et al. Clinical efficacy of CT-guided iodine-125 seed implantation therapy in patients with advanced pancreatic cancer[J]. Eur Radiol, 2010,20(7):1786
[18] 刘树铮. 辐射免疫学研究的回顾与展望[J]. 中华放射医学与防护杂志, 2005, 24(2): 92

相似文献/References:

[1]李辰运,孙 彤,卓 娜,等.胰腺导管腺癌中腺苷酸激酶4 的表达及临床意义[J].天津医科大学学报,2018,24(01):43.
 LI Chen-yun,SUN Tong,ZHUO Na,et al.Expression of AK4 in pancreatic ductal carcinoma and its clinical significance[J].Journal of Tianjin Medical University,2018,24(02):43.
[2]余 冬,冯 霜,李 俊,等.MiR-199a-3p在胰腺癌中的表达水平及生物信息学分析[J].天津医科大学学报,2019,25(02):119.
 YU Dong,FENG Shuang,LI Jun,et al.The expression of miR-199a-3p in pancreatic cancer and bioinformatics analysis[J].Journal of Tianjin Medical University,2019,25(02):119.

备注/Memo

备注/Memo:
基金项目 国家自然科学基金资助项目(81471761、81501568) 作者简介 王艳(1993-),男,硕士在读,研究方向:影像医学与核医学(介入方向);通信作者:郭志,E-mail:cjr.guozhi@vip.163.com。
更新日期/Last Update: 2019-04-25